发明公开
- 专利标题： Influenza Vaccine
- 专利标题（中）： 流感病毒，Impfstoffzusammensetzung
-
申请号： EP05077465.2申请日： 2000-09-27
-
公开(公告)号： EP1618889A2公开(公告)日： 2006-01-25
- 发明人: D'Hondt, Erik , Hehme, Norbert
- 申请人： SmithKline Beecham Biologicals s.a. , Saechsisches Serumwerk Dresden
- 申请人地址： Rue de l'Institut 89 1330 Rixensart BE
- 专利权人： SmithKline Beecham Biologicals s.a.,Saechsisches Serumwerk Dresden
- 当前专利权人： SmithKline Beecham Biologicals s.a.,Saechsisches Serumwerk Dresden
- 当前专利权人地址： Rue de l'Institut 89 1330 Rixensart BE
- 代理机构： Stephen, Robert John
- 优先权： GB9923176 19990930
- 主分类号： A61K39/145
- IPC分类号： A61K39/145 ; A61P31/12
摘要：
The invention provides a monovalent influenza vaccine comprising a low dose of egg-derived influenza virus antigen from an influenza virus strain that is associated with a pandemic outbreak or has the potential to be associated with a pandemic outbreak, in combination with an aluminium adjuvant. The invention also provides vaccine kits comprising a combination of a parenteral and a mucosal influenza vaccine, wherein the combined dose of antigen is no more than the conventional antigen dose. Also provided are methods for preparing the vaccines.
公开/授权文献
- EP1618889B8 Influenza Vaccine 公开/授权日：2011-04-20
信息查询
